The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of BGJ398 in patients (pts) with advanced or metastatic FGFR-altered cholangiocarcinoma (CCA) who failed or are intolerant to platinum-based chemotherapy.
 
Milind M. Javle
No Relationships to Disclose
 
Rachna T. Shroff
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Celgene; Clovis Oncology
Research Funding - Celgene; Lilly
Travel, Accommodations, Expenses - Celgene; Clovis Oncology
 
Andrew Zhu
Honoraria - Blueprint Medicines; Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Eisai
Research Funding - Novartis (Inst)
 
Saeed Sadeghi
Speakers' Bureau - Genentech
 
SuPin Choo
Honoraria - Bayer; Bristol-Myers Squibb; Novartis; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Sanofi
 
Mitesh J. Borad
Research Funding - Novartis (Inst)
 
Maeve Aine Lowery
Consulting or Advisory Role - EMD Serono
 
Anthony El-Khoueiry
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; MedImmune; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; MedImmune; Roche
Research Funding - Astex Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; MedImmune; Roche
 
Teresa Macarulla
No Relationships to Disclose
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
 
Do-Youn Oh
No Relationships to Disclose
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Kun-Huei Yeh
No Relationships to Disclose
 
Randi Isaacs
Employment - Novartis
 
Carolyn McGarry
Employment - Novartis
 
Suman Sen
Employment - Novartis
Travel, Accommodations, Expenses - Novartis
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris